376 related articles for article (PubMed ID: 29700872)
21. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
Nieminen K; Laaksonen K; Savolainen J
Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models.
Vonk MM; Wagenaar L; Pieters RHH; Knippels LMJ; Willemsen LEM; Smit JJ; van Esch BCAM; Garssen J
Clin Transl Allergy; 2017; 7():35. PubMed ID: 29021893
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and immunological changes subjacent to egg oral immunotherapy.
Perezábad L; Reche M; Valbuena T; López-Fandiño R; Molina E; López-Expósito I
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):504-9. PubMed ID: 25935429
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy.
Noval Rivas M; Burton OT; Wise P; Charbonnier LM; Georgiev P; Oettgen HC; Rachid R; Chatila TA
Immunity; 2015 Mar; 42(3):512-23. PubMed ID: 25769611
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy and immune regulation with peanut oral immunotherapy.
Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
[TBL] [Abstract][Full Text] [Related]
27. Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans.
Lozano-Ojalvo D; Tyler SR; Aranda CJ; Wang J; Sicherer S; Sampson HA; Wood RA; Burks AW; Jones SM; Leung DYM; de Lafaille MC; Berin MC
Allergy; 2023 Mar; 78(3):697-713. PubMed ID: 36089900
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells.
Burton OT; Noval Rivas M; Zhou JS; Logsdon SL; Darling AR; Koleoglou KJ; Roers A; Houshyar H; Crackower MA; Chatila TA; Oettgen HC
Immunity; 2014 Jul; 41(1):141-51. PubMed ID: 25017467
[TBL] [Abstract][Full Text] [Related]
29. Innate and adaptive dendritic cell responses to immunotherapy.
Gorelik M; Frischmeyer-Guerrerio PA
Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):575-80. PubMed ID: 26509662
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
[TBL] [Abstract][Full Text] [Related]
31. Dental follicle mesenchymal stem cells down-regulate Th2-mediated immune response in asthmatic patients mononuclear cells.
Genç D; Zibandeh N; Nain E; Gökalp M; Özen AO; Göker MK; Akkoç T
Clin Exp Allergy; 2018 Jun; 48(6):663-678. PubMed ID: 29498435
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
33. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA
Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
[TBL] [Abstract][Full Text] [Related]
34. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
Virkud YV; Wang J; Shreffler WG
Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
[TBL] [Abstract][Full Text] [Related]
35. Human memory CD4+ T cell response to the major dog allergen Can f 5, prostatic kallikrein.
Kailaanmäki A; Kinnunen T; Rönkä A; Rytkönen-Nissinen M; Lidholm J; Mattsson L; Randell J; Virtanen T
Clin Exp Allergy; 2016 May; 46(5):720-9. PubMed ID: 26684878
[TBL] [Abstract][Full Text] [Related]
36. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
Tsai YG; Yang KD; Niu DM; Chien JW; Lin CY
J Immunol; 2010 Jun; 184(12):7229-37. PubMed ID: 20483759
[TBL] [Abstract][Full Text] [Related]
37. Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy.
Yoneyama T; Nakano N; Hara M; Yamada H; Izawa K; Uchida K; Kaitani A; Ando T; Kitaura J; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T
J Allergy Clin Immunol; 2021 Mar; 147(3):1063-1076.e9. PubMed ID: 32717254
[TBL] [Abstract][Full Text] [Related]
38. Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences.
Li L; Boussiotis V
Chem Immunol Allergy; 2008; 94():178-188. PubMed ID: 18802347
[TBL] [Abstract][Full Text] [Related]
39. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
[TBL] [Abstract][Full Text] [Related]
40. Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells.
Lin CL; Hsiao G; Wang CC; Lee YL
Pharmacol Res; 2016 Aug; 110():111-121. PubMed ID: 27185659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
